Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schenkein David P
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   174,790    

Indirect Shares

   417,826      
Direct Value   $6,163,557    

Indirect Value

   $16,623,289      
Total Shares   592,616      
Total Value   $22,786,845      


Agios Pharmaceuticals Inc $5,419,090 Foundation Medicine, Inc. $0 Bluebird Bio, Inc. $6,556 Denali Therapeutics Inc. $445,612 Regeneron Pharmaceuticals Inc $292,299 Agios Pharmaceuticals Inc $5,419,090 Foundation Medicine, Inc. $0 Bluebird Bio, Inc. $6,556 Denali Therapeutics Inc. $445,612 Regeneron Pharmaceuticals Inc $292,299
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 118.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agios Pharmaceuticals Inc AGIO Director 2024-02-27 122,854 2024-02-27 349,854    Premium*  
            Foundation Medicine, Inc. FMI Director 2016-06-16 23,326 2016-06-16 10,508    Premium*  
            Bluebird Bio, Inc. BLUE 2020-06-18 6,832 2014-12-19 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2024-05-31 21,496 2024-05-31 57,464    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 282 2023-09-08 0    Premium*  
* Premium Members only  

Records found :    154         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-24 4 AS $80.01 $1,082,775 D/D (13,533) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-24 4 AS $80.01 $1,600 D/D (20) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-10-27 4 AS $80.26 $321,040 I/I (4,000) 232,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-26 4 AS $80.35 $1,911,494 D/D (23,572) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-03-01 4 AS $80.38 $1,054,218 D/D (13,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-11-03 4 AS $81.71 $1,062,230 I/I (13,000) 124,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-01 4 AS $82.88 $1,079,501 D/D (13,000) 0 0 -
BLUE Bluebird Bio, Inc. Director   –       •      –    2014-12-19 4 B $85.00 $99,960 D/D 1,176 1,176 2.39 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2020-12-21 4 AS $90.01 $450,027 I/I (5,000) 26,232 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2020-12-21 4 AS $90.06 $2,251,555 D/D (25,000) 0 0 %
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-30 4 AS $90.07 $4,109,534 D/D (45,626) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-23 4 AS $90.11 $4,463,524 D/D (49,374) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-04-01 4 AS $92.54 $360,906 I/I (3,900) 237,872 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-05-01 4 AS $93.63 $365,157 I/I (3,900) 231,372 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-06-01 4 AS $94.37 $1,239,608 D/D (13,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-12-01 4 AS $97.03 $1,261,390 I/I (13,000) 118,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-04-13 4 AS $100.03 $390,117 I/I (3,900) 101,201 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-05-08 4 AS $101.32 $395,148 I/I (3,900) 99,901 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-03-02 4 AS $107.05 $834,990 I/I (7,800) 105,101 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-05-11 4 AS $110.01 $341,801 I/I (3,107) 96,794 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-05-12 4 AS $110.03 $230,293 I/I (2,093) 94,701 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-01-02 4 AS $110.08 $1,431,040 I/I (13,000) 111,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-03-05 4 AS $110.16 $286,416 I/I (2,600) 102,501 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-08-03 4 AS $110.60 $884,800 I/I (8,000) 232,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-02-02 4 AS $114.31 $1,188,824 I/I (10,400) 107,872 0 -
  154  Records found
  1   2   3   4   5   6  7      
  Page 6 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us